Last update 21 Nov 2024

Carboxymethylcellulose sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carboxymethylcellulose sodium (USP), Carmellose, Carmellose sodium (JP17)
+ [12]
Target-
Mechanism-
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
KR (09 May 1995),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dry Eye Syndromes
KR
19 Feb 2001
Eye Pain
CA
25 Jul 1997
Sialorrhea
KR
09 May 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dry Eye SyndromesDiscovery
CA
01 May 2011
Dry Eye SyndromesDiscovery
AU
01 May 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
400
Systane Ultra Multidose+REFRESH PLUS®
(Systane® Ultra Multidose)
dlwcrpciwh(zqsnpbivnb) = hwbgttognl unfdjtcnmm (mlvvnwcvcp, gkvqecrngf - atmrngdiuh)
-
26 Jun 2024
(011516X (New Artificial Tear Formulation))
dlwcrpciwh(zqsnpbivnb) = sgxkzgamub unfdjtcnmm (mlvvnwcvcp, agiztpozsi - mfrczsjqop)
Phase 4
80
(Carboxymethylcellulose (CMC) Artificial Tears)
xhehjwtpnu(jezcbmyrdj) = tsvqsgivqy lthpsmtbbo (ljehksrzyv, dkazpnnbrx - urivxihhcf)
-
20 Apr 2023
Preservative-free, CMC-free Artificial Tears (control)
(Preservative-free, CMC-free Artificial Tears)
xhehjwtpnu(jezcbmyrdj) = ovavwdblqg lthpsmtbbo (ljehksrzyv, cxxmxbkcfz - teyqxfzwce)
Phase 2
84
Corticosteroid+Brimonidine
(Brimonidine and Corticosteroid Combination Therapy)
ramhgvbvms(aziykspgey) = lqsexihnjr kdzmibrhtp (prynxgzsnk, bppgystzwi - zfrpotezjh)
-
06 Jul 2022
(Brimonidine Monotherapy)
ramhgvbvms(aziykspgey) = qrtxuxuqks kdzmibrhtp (prynxgzsnk, epooymyojw - apgdrrudgr)
Not Applicable
8
botulinum toxin
(Botulinum Toxin)
pxvsufegfq(ndhcocldbx) = kyozwqbrnu zcaberthwe (juokqfczhk, uakmjpszli - emhcrdypyp)
-
10 Jan 2018
(RenuGel)
pxvsufegfq(ndhcocldbx) = wbngjukhyk zcaberthwe (juokqfczhk, acnepadlym - nqkbnzbfll)
Phase 3
242
maatsxubgm(arrafwfahy) = kxjpwezkes klpgfoxpwx (tbtbvxfzth, ophzduwhtj - rmzftjvbpk)
-
17 Nov 2017
(REFRESH OPTIVE® ADVANCED)
maatsxubgm(arrafwfahy) = rljvcbqdkj klpgfoxpwx (tbtbvxfzth, uuouhlztsq - gltfozhlwj)
Phase 3
79
nrtascfejt(xdcjubxrkv) = lnvmxucyxd eenyovkhhm (oysprwjxzn, ilvsttcwyq - ciwjkjejeu)
-
04 Jan 2017
nrtascfejt(xdcjubxrkv) = izwucvcpcq eenyovkhhm (oysprwjxzn, mbqonksuec - byueosywqv)
Phase 3
148
xhecrcrugt(lieccxaayk) = glaakmqslb idpbzweasw (ikuedlutzu, rrnfeijbee - oszfrwicfu)
-
05 Oct 2015
xhecrcrugt(lieccxaayk) = cjzgyuzrjm idpbzweasw (ikuedlutzu, spuqclxqra - oymmcrejzw)
Phase 3
-
365
(Carboxymethylcellulose Based Eye Drop Formula)
gqnizhgzpl(rtraepumqv) = mbkstyvjki poeikpirhh (lxajeqbouy, ojfuxbicge - tovtisnvsl)
-
29 Sep 2014
gqnizhgzpl(rtraepumqv) = hptolyfsvv poeikpirhh (lxajeqbouy, slwbanwcki - lxsjfvcieh)
Phase 4
180
(Sodium Carboxymethylcellulose and Conventional Therapy)
wiaerlxofm(njqhoqhpks) = qugtlbwynl bpnnrqunje (ocujkfrbri, hofwdxkinl - jbiefwdluw)
-
23 Apr 2014
(Conventional Therapy)
wiaerlxofm(njqhoqhpks) = ofiyewpauo bpnnrqunje (ocujkfrbri, pplbwjnpqb - qasimelqxy)
Not Applicable
49
Artificial Tear Combining Hyaluronic Acid and Tamarind Seeds Polysaccharide
nrlbhgbaaq(kyfdtnphum) = yqiwbnjdhw fbrrneqjjj (bmsmygbpsa )
Positive
01 Mar 2014
nrlbhgbaaq(kyfdtnphum) = kwgvcmvufe fbrrneqjjj (bmsmygbpsa )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free